Eli Lilly’s, Regeneron’s antibody drugs against COVID-19 raise hopes of preventing infection, hospitalisation

Eli Lilly’s study of 1,035 outpatients recently diagnosed with COVID-19 revealed that only 2 percent needed hospitalisation on its drug.

from http://www.firstpost.com/tech/science/eli-lillys-neutralising-antibody-drug-against-covid-19-raises-hope-to-prevent-infection-hospitalisation-9243451.html